Other stimulant dependence with intoxication, unspecified
ICD-10 F15.229 is a billable code used to indicate a diagnosis of other stimulant dependence with intoxication, unspecified.
F15.229 refers to a diagnosis of other stimulant dependence characterized by the presence of intoxication, where the specific stimulant is not identified. Stimulant dependence is a substance use disorder that manifests through a compulsive pattern of use, leading to significant impairment or distress. Symptoms of intoxication may include increased energy, euphoria, decreased appetite, and heightened alertness, but can also lead to adverse effects such as anxiety, paranoia, and cardiovascular complications. The unspecified nature of this code indicates that the specific stimulant (e.g., methamphetamine, cocaine) has not been documented, which can complicate treatment and management strategies. Treatment typically involves a combination of behavioral therapies, counseling, and support groups, as there are no FDA-approved medications specifically for stimulant use disorders. Clinicians must assess the severity of dependence and any co-occurring mental health conditions to tailor an effective treatment plan.
Detailed history of substance use, treatment history, and assessment of co-occurring disorders.
Patients presenting with withdrawal symptoms, seeking detoxification, or requiring rehabilitation.
Ensure comprehensive documentation of the patient's substance use history and any psychiatric evaluations.
Mental status examination, assessment of substance use impact on mental health, and treatment plan.
Patients with dual diagnoses of stimulant dependence and mood disorders.
Document any psychiatric interventions and the rationale for treatment choices.
Used during initial evaluation of a patient with suspected stimulant dependence.
Document the assessment findings and treatment recommendations.
Ensure alignment with addiction medicine protocols.
Document the patient's substance use history, any symptoms of dependence or intoxication, and the treatment plan. Ensure that the clinical notes clearly indicate the lack of specificity regarding the stimulant used.
